Skip to Content
 

News: Home Page Research

Acting NCI director Lowy to present HPV research lecture

Thursday, January 12th, 2017

Douglas R. Lowy, acting director of the National Cancer Institute, will deliver the Vanderbilt-Ingram Cancer Center George Daniel Brooks Lecture at Vanderbilt University Medical Center on Tuesday, Jan. 24, at 11 a.m. in Light Hall, Room 208. The title of the presentation is “Preventing HPV-associated Cancers: Short-term and Long-term Approaches.” Lowy is chief of the […]

Moses elected to National Academy of Inventors

Wednesday, January 4th, 2017

Harold (Hal) Moses, M.D., Ingram Professor of Cancer Research and director emeritus of Vanderbilt-Ingram Cancer Center (VICC), has been named a Fellow of the National Academy of Inventors (NAI). Moses, professor and interim chair of Cancer Biology, is among 175 academic leaders named to the 2016 class of NAI Fellows. Harold L. (Hal) Moses, M.D. […]

Study to explore lymphedema self care for cancer survivors

Thursday, December 15th, 2016

Vanderbilt University School of Nursing (VUSN) Assistant Professor Jie Deng, Ph.D., R.N., has been awarded a $789,000 research scholar grant by the American Cancer Society to develop and test a self-care program for head and neck cancer survivors diagnosed with secondary lymphedema and fibrosis (LEF). LEF causes swelling and the development of hard tissue in […]

Study links lifestyle factors to formation of high-risk polyps

Thursday, December 8th, 2016

Lifestyle factors like cigarette smoking and red meat consumption are known to be associated with an increased risk of colon polyps that can lead to colorectal cancer. Polyps are small growths on the lining of the colon, and while some polyps are harmless others can progress to cancer. A new study led by Vanderbilt University […]

Targeting the “un-targetable”

Thursday, December 1st, 2016

Triple negative breast cancers (TNBC) are so named because they lack common genetic “target” mutations that can be easily treated with specific cancer drugs. However, in a recent study published in Molecular Cancer Therapeutics, Deborah Lannigan, Ph.D., and colleagues investigated a new target involved in TNBC called RSK. They demonstrated that RSK can help cancers […]

V Foundation grants bolster cancer initiatives

Thursday, November 17th, 2016

Two Vanderbilt-Ingram Cancer Center (VICC) investigators have earned grant awards from The V Foundation for Cancer Research, continuing the foundation’s support for innovative cancer research initiatives at VICC. Raymond Blind, Ph.D., assistant professor of Medicine, Biochemistry and Pharmacology, has received a two-year V Foundation grant to examine how proteins induce cancerous tumors to grow. Blind’s […]

A DARPP role in gastric cancer

Monday, November 7th, 2016

Infection with Helicobacter pylori bacterium affects almost half of the world’s population. Chronic infection with H. pylori and its associated inflammation are considered the main risk factors for the development of gastric cancer, the third leading cause of cancer-related deaths worldwide. Previously, Wael El-Rifai, M.D., Ph.D., and colleagues had discovered that DARPP-32 protein, overexpressed in […]

Single-cell study of tumor samples

Monday, October 31st, 2016

The presence of various cell types in tumors – cellular heterogeneity – makes treatment challenging, since a therapy may kill one cell type but not affect another. Studying heterogeneous cell populations requires single-cell analysis. Ken Lau, Ph.D., and colleagues previously described a method for preparing single-cell suspensions from epithelial tissues – the type of tissue […]

EGF receptor found to regulate macrophage inflammation in gut

Thursday, October 13th, 2016

Researchers at Vanderbilt University School of Medicine have uncovered a link between epidermal growth factor receptor (EGFR) signaling and the inflammatory response to bacterial infection in the gastrointestinal tract. In particular, they have found — in mice and human tissue — that EGFR signaling regulates the response of an inflammatory macrophage (a type of white […]

Vanderbilt scientists to lead chronic disease research initiative in Vietnam

Thursday, October 6th, 2016

Scientists in the Vanderbilt Epidemiology Center (VEC) and Vanderbilt-Ingram Cancer Center (VICC) have been awarded a grant to plan and develop a Regional Center of Research Excellence in non-communicable diseases in Vietnam. Xiao Ou Shu, M.D., Ph.D., MPH, associate director for Global Health and co-leader of the Cancer Epidemiology Research Program at VICC, and Thuan […]

Next Page »« Previous Page